Richard L. Sidman, MD
Affiliations: | Harvard Medical School, Boston, MA, United States |
Area:
Neuropathology, neuroimaging, neuronal migration, geneticsWebsite:
http://research.bidmc.harvard.edu/research/ResearchPIInfo.ASP?Submit=Display&PersonID=12977Google:
"Richard Sidman"Mean distance: 13.2 (cluster 11) | S | N | B | C | P |
Children
Sign in to add traineeStory C. Landis | grad student | Harvard Medical School | |
Jeffrey D. Macklis | grad student | Harvard Medical School | |
Daniel Goldowitz | post-doc | Harvard Medical School | |
Mary E. Hatten | post-doc | Harvard | |
Jaime Imitola | post-doc | ||
Jeffrey D. Macklis | post-doc | Harvard Medical School | |
Melitta Schachner | post-doc | Harvard Medical School | |
Verne S. Caviness, Jr. | post-doc | 1969-1971 | Harvard Medical School |
Matthew LaVail | post-doc | 1969-1973 | Harvard Medical School |
Jerry Silver | post-doc | 1974-1976 | Harvard Medical School |
Harold David Shine | post-doc | 1980-1988 | Brigham and Women's Hospital |
Daniel A. KIRSCHNER | research scientist | 1975-1980 | Boston College |
Vaclav Ourednik | research scientist | 1998-2001 | Harvard Medical School |
M Zeeshan Ozair | research scientist | 2003-2004 | Beth Israel Deaconess Medical Center / Harvard Medical School |
Collaborators
Sign in to add collaboratorNorman Weiner | collaborator | 1960-1967 | Harvard Medical School |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Nomoto M, Konopaske GT, Yamashita N, et al. (2021) Clinical evidence that a dysregulated master neural network modulator may aid in diagnosing schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 118 |
Lee JP, Zhang R, Yan M, et al. (2020) Chemical mutagenesis of a GPCR ligand: Detoxifying "inflammo-attraction" to direct therapeutic stem cell migration. Proceedings of the National Academy of Sciences of the United States of America |
Li J, Snyder EY, Tang FH, et al. (2020) Nna1 gene deficiency triggers Purkinje neuron death by tubulin hyperglutamylation and ER dysfunction. Jci Insight. 5 |
Hartman RE, Nathan NH, Ghosh N, et al. (2020) A Biomarker for Predicting Responsiveness to Stem Cell Therapy Based on Mechanism-of-Action: Evidence from Cerebral Injury. Cell Reports. 31: 107622 |
Pernia CD, Nathan NH, Tobe BTD, et al. (2018) Modeling Complex Neurological Diseases with Stem Cells: A Study of Bipolar Disorder. Results and Problems in Cell Differentiation. 66: 265-282 |
Staquicini DI, Rangel R, Guzman-Rojas L, et al. (2017) Intracellular targeting of annexin A2 inhibits tumor cell adhesion, migration, and in vivo grafting. Scientific Reports. 7: 4243 |
Tobe BTD, Crain AM, Winquist AM, et al. (2017) Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesis. Proceedings of the National Academy of Sciences of the United States of America |
Kanamaru Y, Li J, Stewart N, et al. (2017) Cerebellar Pathways in Mouse Model of Purkinje Cell Degeneration Detected by High-Angular Resolution Diffusion Imaging Tractography. Cerebellum (London, England) |
Ropper AE, Thakor DK, Han I, et al. (2017) Defining recovery neurobiology of injured spinal cord by synthetic matrix-assisted hMSC implantation. Proceedings of the National Academy of Sciences of the United States of America |
Abelin JG, Patel J, Lu X, et al. (2016) Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes. Molecular & Cellular Proteomics : McP |